Skip to main content
Support Quality Journalism.
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just
$1.99
per week
for first 24 weeks
Enjoy unlimited digital access
START TODAY
Get full access to globeandmail.com
Just $1.99 per week
for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
The Globe and Mail
Member Benefits
Subscribe
Subscribe
Register
Log in
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
My account
Following
Bookmarks
Reading history
Newsletters
Subscriptions
Settings
Help
AdChoices
Canada
World
Business
Investing
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Watchlist
Search
Search
Quick links
Horoscopes
Puzzles
Member Benefits
Newsletters
Globe Shop
Investigations
Death Notices (Legacy.com)
Reader services
Subscribe
Following
Subscriptions
Settings
Customer Help
Contact us
Log in
Log out
Purdue Pharma
Follow
Latest
international business
McKinsey’s top executive voted out as consulting firm faces reckoning over opioid crisis
February 24
Updated
opinion
Either way, Dominic Barton’s plea of ignorance makes Justin Trudeau look bad
Konrad Yakabuski
February 12
Updated
canada
At the root of the opioid crisis is our belief that Big Pharma can cure pain. Can we kick that habit?
January 9
Updated
u.s. business
Sacklers cited fear of OxyContin lawsuits before transferring US$10-billion from Purdue Pharma, documents show
December 21
Updated
international business
OxyContin maker Purdue Pharma pleads guilty in criminal case
November 24
Updated
canada
Canada’s provinces have filed opioid-related claims totalling $67.4-billion in U.S. court
November 12
Updated
More Stories Below Advertisement
u.s. business
McKesson says cost of opioid settlements could reach $21-billion
November 3
Updated
u.s. business
New York University to strip Sackler name from its Langone Medical Center following Purdue Pharma deal
October 22
Updated
international business
OxyContin maker Purdue Pharma to plead guilty to three criminal charges as part of settlement
October 21
Updated
u.s. business
U.S. pursues nearly $13-billion of claims in Purdue Pharma opioid probes, sources say
August 5
Updated
international business
U.S. pursues nearly $13-billion of penalties in Purdue Pharma opioid probes
August 4
Updated
obituary
Jonathan Sackler, co-owner of OxyContin-maker Purdue Pharma, dies at 65
July 6
Updated
u.s. business
Owners of OxyContin maker Purdue Pharma were paid more after company’s big fine for misleading marketing
December 16, 2019
Updated
morning update newsletter
Morning Update: Elections Alberta changes course; Pressure grows on Malta PM; Lobsters and the trade war
November 29, 2019
Updated
canada
Purdue Pharma asks court to halt all litigation against it in Canada amid U.S. lawsuits
November 28, 2019
Updated
british columbia
More provinces join in class-action suit against opioid makers
August 27, 2019
Updated
More Stories Below Advertisement
canada
B.C. alleges 20 years of deception in opioid lawsuit
August 29, 2018
Updated
canada
B.C. to sue opioid makers for health-care expenses of overdose crisis
August 28, 2018
Updated
To view this site properly, enable cookies in your browser. Read our
privacy policy
to learn more.
How to enable cookies